PHOENIX, ARIZONA — MAY 23, 2023 — A $726,000 donation from Atlanta-based charity Purple Pansies will support a TGen-led clinical trial designed to increase a patient’s unfolded protein response (UPR) to push the cancer cells to reach a state of programmed cell death. UPR is a cellular defense mechanism that, when triggered, sends signals to the cell’s nucleus to restore balance and ensure that proteins are folded properly, which is essential for normal cell function.Continue reading
Category Archives: AZBio News
Ivy Brain Tumor Center Builds On Innovative Clinical Trial Program by Appointing New Chief Medical Officer
Leading Neuro-Oncologist Yoshie Umemura, MD, Joins Barrow Neurological InstituteContinue reading
AZAdvances Talent Receives Grant to Support STEM Workforce Opportunities
Senator Sinema lauds efforts to further fund growing internship program for Arizona studentsContinue reading
Xcellerant and Flinn Foundation Partner to Fuel Growth in Arizona Bioscience and Healthcare Sectors
SCOTTSDALE, Ariz–(BUSINESS WIRE)–Xcellerant Ventures (XVC) welcomes the Flinn Foundation as a limited partner in its Xcellerant Venture Capital Fund I. Xcellerant Ventures is a venture capital firm investing in early and seed stage startups within the HealthTech and MedTech sectors. Xcellerant seeks to invest in dynamic founding teams with strong intellectual property portfolios that XVC believes will transform medical practice and dramatically improve healthcare.
A century later, HonorHealth Research Institute examines first potentially effective treatment for Lou Gehrig’s Disease
HonorHealth Research Institute is one of just 30 sites worldwide participating in this first ALS prevention study, sponsored by Biogen. The focus of the study is to identify individuals who are genetically predisposed to acquiring ALS, specifically those who carry the SOD1 gene but who don’t yet show any symptoms.Continue reading
GT Medical Technologies Marks a Significant Milestone: The 1,000th Order for GammaTile® Therapy
TEMPE, Ariz., May 18, 2023 /PRNewswire/ — GT Medical Technologies, Inc. announced receipt of the 1,000th order for GammaTile Therapy.
Driven to overcome the limitations of current treatments for brain tumors and improve the standard of care, a team of brain tumor specialists joined forces to form GT Medical Technologies, Inc. GammaTile Surgically Targeted Radiation Therapy (STaRT) is the newest option for patients undergoing brain tumor resection. Continue reading
HonorHealth Research Institute collaborator Worldwide Clinical Trials expands Site Alliance Collaboration to support oncology trials
RESEARCHTRIANGLE PARK, N.C. and SCOTTSDALE, ARIZ. – In response to the growing and ever-changing clinical research landscape and the need to bring innovative treatments to patients faster, Worldwide Clinical Trials (Worldwide), a leading global, full-service contract research organization (CRO), has expanded its Site Alliance Collaboration with new partners across the United States and Europe.Continue reading
Opportunity Alert: Apply for a FAST Grant by July 10th
The Small Business Administration’s Federal and State Technology (FAST) Partnership Program is designed to support programs that advance innovative, technology-driven small businesses. The Arizona Commerce Authority has partnered with the Small Business Administration (SBA) to facilitate the FAST program in Arizona.Continue reading
Castle Biosciences’ TissueCypher® Barrett’s Esophagus Test Receives 2023 MedTech Breakthrough Award for Artificial Intelligence Innovation
This marks the third consecutive year that Castle has been recognized with a MedTech Breakthrough Award for its innovative testing solutionsContinue reading
Advocacy Matters: Learn How Advocacy Impacts Health Innovation
On May 16, 2023, advocacy took center stage on AZBioPEERS, with a discussion on how Advocacy Matters with leaders from Washington, D.C. and Arizona. Continue reading